Overview

A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Status:
Completed
Trial end date:
2017-06-19
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether BMS-986036 is effective in the treatment of subjects with Non-alcoholic Steatohepatitis (NASH).
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Bristol-Myers Squibb
Criteria
For more information regarding BMS clinical trial participation, please visit
www.BMSStudyConnect.com

Inclusion Criteria:

- Male or female between 21 and 75 years old

- Body Mass Index (BMI) of 25 or more

Exclusion Criteria:

- Chronic Liver disease other than NASH

- Uncontrolled diabetes

- Any major surgery within 6 weeks of screening

- Unable to self-administer under the skin injections

- Any bone trauma, fracture or bone surgery within 8 weeks of screening